A multicentric, retrospective, cohort study evaluating the efficacy and safety of Ado-trastuzumab Emtansine in patients with central nervous system metastases of HER2 positive breast cancers.
Latest Information Update: 18 Jul 2016
At a glance
- Drugs Trastuzumab emtansine (Primary)
- Indications Advanced breast cancer; CNS cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Jul 2016 New trial record
- 07 Jun 2016 Results (n=14) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology